INMD Q2 Net Rose 45% to $1.6M; Adj. EBITDA rose 23% to $52.M and EPS rose 8% to $0.14

Jul. 27, 2010 9:34 AM ETINMD-OLD
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Value, Growth, Deep Value, Special Situations

Contributor Since 2006

I am an investor relations consultant with nearly 30 years experience steering IR strategy and outreach for 100+ companies across a range of industries. We launched Catalyst IR in 2012 as a platform for innovating IR to better address the realities of small- and micro-cap companies. We deliver senior level experience and counsel with targeted outreach and efficient communications to create real change and share price results for "smidcap" companies in today's markets. 

Relationships and credibility take time - there is no shortcut - and are rooted in integrity, candor and a focus on ROI. I post on Seeking Alpha to expand the reach of client stories as well as other investments we like. The online networking of ideas is integral to the IR function - and it's fun! 

My posts are NOT endorsed by the subject companies - client or otherwise. We believe in truth and fair play at all times - period - and we gravitate to those who share that view. Enjoy and be careful!

on 10% increase in revenue to $61.7mm.

1st half Revenue was $118.8mm and 1H EPS is $0.25

http://finance.yahoo.com/news/IntegraMed-Q2-Net-Income-Rose-bw-787960958.html?x=0&.v=1


Disclosure: IR Counsel - No Position

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.